SCHEMBL7435904

SCHEMBL7435904

CC(N)C(O)CCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.62
GABRD O14764 2/20 0.62
GABRA1 P14867 2/20 0.62
GABRB1 P18505 2/20 0.62
GABRG2 P18507 2/20 0.62
GABRB3 P28472 2/20 0.62
GABRA5 P31644 2/20 0.62
GABRA3 P34903 2/20 0.62
GABRA2 P47869 2/20 0.62
GABRB2 P47870 2/20 0.62
GABRA4 P48169 2/20 0.62
GABRE P78334 2/20 0.62
GABRA6 Q16445 2/20 0.62
GABRG1 Q8N1C3 2/20 0.62
GABRG3 Q99928 2/20 0.62
GABRQ Q9UN88 2/20 0.62
TRPV1 Q8NER1 1/20 0.52
TRPA1 O75762 1/20 0.52
CYP1A2 P05177 2/20 0.50
GRM8 O00222 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547284 0.85 TRPV1 (0.64) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31182378 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2291764 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL3692400 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31629424 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL25424616 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7382810 0.80 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10599631 0.79 TET2 (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10827460 0.79 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10431128 0.79 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5230095-A None JP disclosed
JP-7316191-A None JP disclosed
CN-101484149-B There is the pharmaceutical dosage form of the separate layer of multilamellar EVONIK ROHM GMBH (DE) 2015-12-02 CN disclosed
US-5643878-A TREATMENT OF RETROVIRAL DISEASES LIKE AIDS CIBA-GEIGY CORPORATION (US) 1997-07-01 US disclosed
US-5643878-A TREATMENT OF RETROVIRAL DISEASES LIKE AIDS CIBA-GEIGY CORPORATION (US) 1997-07-01 US disclosed
JP-H07316191-A ACYLOXYHEXANOIC ACID DERIVATIVE CIBA GEIGY AG 1995-12-05 JP disclosed
CN-1112125-A Acyloxyhexanoic acid derivatives CIBA GEIGY AG (CH) 1995-11-22 CN disclosed
EP-0618222-A2 Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid CIBA-GEIGY AG (CH) 1994-10-05 EP disclosed
CN-1089269-A Novel 5-amino-4-hydroxy caproic acid derivative as therapeutical agent CIBA GEIGY AG (CH) 1994-07-13 CN disclosed
CN-1089269-A Novel 5-amino-4-hydroxy caproic acid derivative as therapeutical agent CIBA GEIGY AG (CH) 1994-07-13 CN disclosed
JP-H05230095-A NEW-5-AMINO-4-HYDROXYHEXANOIC ACID DERIVATIVE AS DRUG CIBA GEIGY AG 1993-09-07 JP disclosed
EP-0532466-A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use CIBA-GEIGY AG (CH) 1993-03-17 EP disclosed